DDS financial statements and SEC filings
DDS annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2026-01-31 | $6.56B | – | $570.19M | 10-K |
| 2025-02-01 | $6.59B | – | $593.48M | 10-K |
| 2024-02-03 | $6.87B | – | $738.85M | 10-K |
| 2023-01-28 | $7.00B | – | $891.64M | 10-K |
| 2022-01-29 | $6.62B | – | $862.47M | 10-K |
| 2021-01-30 | $4.43B | – | -$71.65M | 10-K |
DDS annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2026-01-31 | $3.51B | $1.73B | $1.78B | 10-Q |
| 2025-02-01 | $3.53B | $1.73B | $1.80B | 10-K |
| 2024-02-03 | $3.45B | $1.75B | $1.70B | 10-K |
| 2023-01-28 | $3.33B | $1.73B | $1.60B | 10-K |
| 2022-01-29 | $3.25B | $1.79B | $1.45B | 10-K |
| 2021-01-30 | $3.09B | $1.65B | $1.44B | 10-K |
DDS annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2026-01-31 | $717.01M | -$93.38M | -$595.94M | 10-K |
| 2025-02-01 | $714.13M | -$104.55M | -$534.83M | 10-K |
| 2024-02-03 | $883.59M | -$132.94M | -$620.04M | 10-K |
| 2023-01-28 | $948.39M | -$120.11M | -$768.97M | 10-K |
| 2022-01-29 | $1.28B | -$104.36M | -$853.81M | 10-K |
| 2021-01-30 | $252.95M | -$60.45M | -$121.30M | 10-K |